# RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)

> **NCT06305806** · PHASE2 · COMPLETED · sponsor: **Kanecia Obie Zimmerman** · enrollment: 181 (actual)

## Conditions studied

- Long COVID
- Long Covid19
- Long Covid-19

## Interventions

- **DRUG:** Ivabradine
- **DRUG:** Ivabradine Placebo
- **BEHAVIORAL:** Coordinated Care
- **BEHAVIORAL:** Usual Care

## Key facts

- **NCT ID:** NCT06305806
- **Lead sponsor:** Kanecia Obie Zimmerman
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-11
- **Primary completion:** 2025-10-13
- **Final completion:** 2025-12-17
- **Target enrollment:** 181 (ACTUAL)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06305806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06305806, "RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT06305806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*